{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:41:33Z","timestamp":1788309693805,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Paediatric Rheumatology International Trials Organisation (PRINTO) criteria for clinically inactive disease (CID) and their proposal for glucocorticoid tapering do not consider MRI findings, despite the growing use of MRI and development of reliable MRI scoring tools. We aim to evaluate how CID correlates with MRI scores and physician decision making. We retrospectively used the Juvenile Dermatomyositis Imaging Score (JIS) to score MRIs of all children with JDM over a 10-year period. Demographic, diagnosis, treatment and core set measures data were collected. Correlation between CID and JIS was assessed as well as correlation with the physician treatment decision. There were 25 patients with 59 follow-up episodes to analyse correlation between physician treatment decision and JIS; and 50 episodes for the CID category and JIS correlation. JIS was not significantly associated with the CID category but did correlate with the physician decision. No significant association was found between clinical decision and CID category. The JIS area under the ROC curve (AUC) was 0.80 (95% CI 0.62\u20130.99) with a score\u2009\u2265\u20098 to predict an escalation. JIS sensitivity and specificity were both 78% with accuracy of 78%, compared to only 67%, 46% and 49%, respectively, for the CID criteria. Clinical criteria alone are not sufficient to assess disease activity status. Clinical decision trends correlated to MRI findings but not PRINTO CID criteria. Multi centre prospective studies are needed to replicate our findings and establish how to best use MRI as a biomarker of disease activity.<\/jats:p>","DOI":"10.1007\/s00296-021-05049-1","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T17:04:09Z","timestamp":1637255049000},"page":"1221-1226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically inactive disease: a single-centre retrospective evaluation"],"prefix":"10.1007","volume":"42","author":[{"given":"Kapil","family":"Gargh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-6341","authenticated-orcid":false,"given":"Eslam","family":"Al-Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2504-2971","authenticated-orcid":false,"given":"William","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"issue":"10","key":"5049_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","volume":"45","author":"LJ McCann","year":"2006","unstructured":"McCann LJ, Juggins AD, Maillard SM et al (2006) The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2013clinical characteristics of children recruited within the first 5 year. Rheumatology 45(10):1255\u20131260. https:\/\/doi.org\/10.1093\/rheumatology\/kel099","journal-title":"Rheumatology"},{"issue":"3","key":"5049_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","volume":"43","author":"AM Huber","year":"2000","unstructured":"Huber AM, Lang B, LeBlanc CM et al (2000) Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 43(3):541\u2013549. https:\/\/doi.org\/10.1002\/1529-0131(200003)43:3%3c541::AID-ANR9%3e3.0.CO;2-T","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5049_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli A, Trail L, Ferrari C et al (2010) Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res 62(1):63\u201372. https:\/\/doi.org\/10.1002\/acr.20015","journal-title":"Arthritis Care Res"},{"issue":"5","key":"5049_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/acr.22212","volume":"66","author":"AM Huber","year":"2014","unstructured":"Huber AM, Mamyrova G, Lachenbruch PA et al (2014) Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res 66(5):732\u2013740. https:\/\/doi.org\/10.1002\/acr.22212","journal-title":"Arthritis Care Res"},{"issue":"10019","key":"5049_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"N Ruperto","year":"2016","unstructured":"Ruperto N, Pistorio A, Oliveira S et al (2016) Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet 387(10019):671\u2013678. https:\/\/doi.org\/10.1016\/S0140-6736(15)01021-1","journal-title":"Lancet"},{"issue":"5","key":"5049_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","volume":"72","author":"D Lazarevic","year":"2013","unstructured":"Lazarevic D, Pistorio A, Palmisani E et al (2013) The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 72(5):686\u2013693. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201483","journal-title":"Ann Rheum Dis"},{"key":"5049_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12969-019-0326-5","volume":"17","author":"G Giancane","year":"2019","unstructured":"Giancane G, Lavarello C, Pistorio A et al (2019) The PRINTO evidence-based proposal for glucocorticoids tapering\/discontinuation in new onset juvenile dermatomyositis patients. Pediatr Rheumatol 17:24. https:\/\/doi.org\/10.1186\/s12969-019-0326-5","journal-title":"Pediatr Rheumatol"},{"issue":"1","key":"5049_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"N Ruperto","year":"2008","unstructured":"Ruperto N, Ravelli A, Pistorio A et al (2008) The provisional Paediatric Rheumatology International Trials Organisation\/American College of Rheumatology\/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 59(1):4\u201313. https:\/\/doi.org\/10.1002\/art.23248","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5049_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/acr.22041","volume":"65","author":"R Qui\u00f1ones","year":"2013","unstructured":"Qui\u00f1ones R, Morgan GA, Amoruso M, Field R, Huang CC, Pachman LM (2013) Lack of achievement of a full score on the childhood myositis assessment scale by healthy four-year-olds and those recovering from juvenile dermatomyositis. Arthritis Care Res 65(10):1697\u20131701. https:\/\/doi.org\/10.1002\/acr.22041","journal-title":"Arthritis Care Res"},{"issue":"11","key":"5049_CR10","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM et al (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 63(11):S118\u2013S157. https:\/\/doi.org\/10.1002\/acr.20532","journal-title":"Arthritis Care Res"},{"issue":"3","key":"5049_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/acr.22142","volume":"66","author":"AB Robinson","year":"2014","unstructured":"Robinson AB, Hoeltzel MF, Wahezi DM et al (2014) Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care Res 66(3):404\u2013410. https:\/\/doi.org\/10.1002\/acr.22142","journal-title":"Arthritis Care Res"},{"issue":"2","key":"5049_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"F Bellutti Enders","year":"2017","unstructured":"Bellutti Enders F, Bader-Meunier B, Baildam E et al (2017) Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis 76(2):329\u2013340. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209247","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5049_CR13","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/ker262","volume":"50","author":"WR Davis","year":"2011","unstructured":"Davis WR, Halls JE, Offiah AC, Pilkington C, Owens CM, Rosendahl K (2011) Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system. Rheumatology 50(12):2237\u20132244. https:\/\/doi.org\/10.1093\/rheumatology\/ker262","journal-title":"Rheumatology"},{"issue":"9","key":"5049_CR14","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/rheumatology\/key144","volume":"57","author":"M Thyoka","year":"2018","unstructured":"Thyoka M, Adekunle O, Pilkington C et al (2018) Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis. Rheumatology 57(9):1661\u20131668. https:\/\/doi.org\/10.1093\/rheumatology\/key144","journal-title":"Rheumatology"},{"issue":"10","key":"5049_CR15","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1002\/art.30475","volume":"63","author":"R Hasija","year":"2011","unstructured":"Hasija R, Pistorio A, Ravelli A, Demirkaya E, Khubchandani R, Guseinova D (2011) Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. Arthritis Rheum 63(10):3142\u20133152. https:\/\/doi.org\/10.1002\/art.30475","journal-title":"Arthritis Rheum"},{"issue":"5","key":"5049_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/rheumatology\/keh130","volume":"43","author":"SM Maillard","year":"2004","unstructured":"Maillard SM, Jones R, Owens C et al (2004) Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 43(5):603\u2013608. https:\/\/doi.org\/10.1093\/rheumatology\/keh130","journal-title":"Rheumatology"},{"issue":"11","key":"5049_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11926-015-0544-x","volume":"17","author":"B Maurer","year":"2015","unstructured":"Maurer B, Walker UA (2015) Role of MRI in diagnosis and management of idiopathic inflammatory myopathies. Curr Rheumatol Rep 17(11):67. https:\/\/doi.org\/10.1007\/s11926-015-0544-x","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"5049_CR18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","volume":"73","author":"C Malattia","year":"2014","unstructured":"Malattia C, Damasio MB, Madeo A et al (2014) Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis 73(6):1083\u20131090. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202915","journal-title":"Ann Rheum Dis"},{"key":"5049_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-017-0154-4","volume":"15","author":"R Abdul-Aziz","year":"2017","unstructured":"Abdul-Aziz R, Yu CY, Adler B et al (2017) Muscle MRI at the time of questionable disease flares in juvenile dermatomyositis (JDM). Pediatr Rheumatol 15:1\u20136. https:\/\/doi.org\/10.1186\/s12969-017-0154-4","journal-title":"Pediatr Rheumatol"},{"key":"5049_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1749-6632.2009.04498.x","volume":"1154","author":"JM Gardner-Medwin","year":"2009","unstructured":"Gardner-Medwin JM, Irwin G, Johnson K (2009) MRI in juvenile idiopathic arthritis and juvenile dermatomyositis. Ann N Y Acad Sci 1154:52\u201383. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04498.x","journal-title":"Ann N Y Acad Sci"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-05049-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:09:09Z","timestamp":1655370549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-05049-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5049"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-05049-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"15 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This review of service was registered with, and approved by, the Clinical Audit Registration and Management System within our institution (code number: CARMS-30374).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}